Stay updated with breaking news from Global External. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Three poster presentations showing the beneficial effects of lanifibranor on markers of cardiometabolic health in patients with non-cirrhotic NASH fibrosis independent of weight gain observed.the reduction
Inventiva has been selected for inclusion in Euronext's new segment alongside more than 100 high-growth and Tech-driven European companiesInternational investors will be able to track the Euronext Tech
Investegate announcements from INVENTIVA, Inventiva joins the Euronext Tech Leaders segment
Daix (France), Long Island City (New York, United States), June 3, 2022 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small
Investegate announcements from INVENTIVA, Inventiva announces the presentation of a scientific abstract at the 82nd Scientific Sessions of the American Diabetes Association